News

BDSI filed the new drug application (NDA) in late April 2005, and this written notification indicates that the FDA review of the product is now underway. The FDA

The study, designed to evaluate NicVAX’s safety, antibody response to nicotine, and efficacy, will monitor the effects of 100, 200, 300, and 400mcg injections, over a six-month period.

Betaferon is already an approved and widely used treatment for relapsing-remitting multiple sclerosis (RRMS) in a 250mcg dose. However, the study now seeks to ascertain whether patients could

SPI-339 is an orally available small molecule drug that has potential applications for the treatment of attention disorders, memory acquisition and other cognitive functions. The company hopes that

The company had previously stated that it had reduced its supply expectations for Begrivac in non-US markets from 12 million doses to just four million. However, it now

In most cases, hemophilia is caused by a lack of factor VIII, one of several proteins that enable blood to solidify, or clot, to plug wounds after injury.

With Evotec’s state-of-the-art integrated autopurification and analytical platforms each compound will be of the highest purity to deliver high quality results in Almirall’s pharmaceutical screening and medicinal chemistry

The fast track designation has been awarded to the drug as it is intended for the treatment of a serious or life-threatening condition, and demonstrates the potential to

The RxWise tool, which can be accessed via the web or USB Flash Drive, is designed to evaluate the potential risks for an adverse drug reaction (ADR) by